Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: A case for recommending hysterectomy at surgical prophylaxis

Gynecologic Oncology

Volumn 80, Issue 2, 2001, Pages 176-180

  Paley, Pamela J ^a   Swisher, Elizabeth M ^a   Garcia, Rochelle L ^a   Agoff, S Nicholas ^a   Greer, Benjamin E ^a   Peters, Ksenia L ^a   Goff, Barbara A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

BRCA 1 mutation; Fallopian tube cancer; Surgical prophylaxis

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CASE REPORT; FEMALE; GENE MUTATION; GERM LINE; HETEROZYGOTE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; OCCULT CANCER; ONCOGENE; OVARIECTOMY; OVARY CANCER; PRIORITY JOURNAL; PROPHYLAXIS; UTERINE TUBE CARCINOMA;

EID: 0035137888     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2000.6071     Document Type: Article

References (18)

1. Carcinoma of the fallopian tube
2. Linkage analysis of 25 Canadian breast and breast-ovarian cancer families
3. BRCA1 gene mutations in sporadic ovarian carcinomas - Detection by PCR and reverse transcriptase allele-specific oligonucleotide hybridization
4. BRCA2 in American families with four or more cases of breast or ovarian cancer - Recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2
5. Germline BRCA2 mutation in a patient with fallopian tube carcinoma - A case report
6. Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations
7. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
8. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
9. Risks of cancer in BRCA1-mutation carriers
10. Cancer risks in BRCA2 mutation carriers
11. BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum
12. Evidence of a founder BRCA1 mutation in Scotland
13. Statement of the American Society of Clinical Oncology - Genetic testing for cancer susceptibility
14. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer - A report of the Gilda Radner Familial Ovarian Cancer Registry
15. Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families
16. Prophylactic oophorectomy in inherited breast/ovarian cancer families
17. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers
18. Tamoxifen for prevention of breast cancer - Report of the national surgical adjuvant breast and bowel project p-study